| Bioactivity | 6A-Azido-6A-deoxy-β-cyclodextrin (β-CDN3; 6A-deoxy-6A-azido-β-cyclodextrin) is a new water-soluble Schiff base ligand based on β-cyclodextrin (HY-107201). 6a-Azido-6a-deoxy-β-cyclodextrin can be used for biaqueous hydroformylation. β-cyclodextrin (βCD) has a unique affinity for Dexamethasone (HY-14648), and can be used as a topical osmotic enhancer to introduce it into the drug carrier system[1][2]. | ||||||||||||
| Name | 6A-Azido-6A-deoxy-β-cyclodextrin | ||||||||||||
| CAS | 98169-85-8 | ||||||||||||
| Formula | C42H69N3O34 | ||||||||||||
| Molar Mass | 1160.00 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Dauchy M, et al. New water-soluble Schiff base ligands based on β-cyclodextrin for aqueous biphasic hydroformylation reaction[J]. Pure and Applied Chemistry, 2018, 90(5): 845-855. [2]. Giulbudagian M, et al. Enhanced topical delivery of dexamethasone by β-cyclodextrin decorated thermoresponsive nanogels. Nanoscale. 2017 Dec 21;10(1):469-479. |